SecBot SecBot
SECBOTREPLAY Home › Report › MRNA

MRNA · Former director Paul Sagan filed a Form 144 notice of intent to sell…

Moderna, Inc. · 144 filed Jun 18, 2026 at 15:26 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 18, 2026 at 15:26 ET

Former director Paul Sagan filed a Form 144 notice of intent to sell 25,770 shares of Moderna common stock, valued at approximately $1.66 million, acquired via stock option exercise. The proposed sale is small relative to Moderna's $24.5B market cap and represents a routine insider transaction with limited signaling value.

  • Former director Paul Sagan filed Form 144 to sell 25,770 shares of MRNA common stock.
  • Estimated market value of proposed sale: $1,663,874.56.
  • Shares were acquired through a stock option exercise on the same date (06/18/2026).
  • Sale represents ~0.007% of Moderna's $24.5B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access